MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 1941 to 1960 of 166,322 approvalsPage 98 of 8317

Bisoprolol Fumarate Tablets

Approval Number: 国药准字H20253013
Registration: Jan 2, 2025

Ibrutinib Tablets

Approval Number: 国药准字H20253032
Registration: Jan 2, 2025

Oseltamivir Phosphate for Suspension

Approval Number: 国药准字H20253060
Registration: Jan 2, 2025

Roxadustat Capsules

Approval Number: 国药准字H20253058
Registration: Jan 2, 2025

Ceftizoxime Sodium for Injection

Approval Number: 国药准字H20253050
Registration: Jan 2, 2025

Dapoxetine Hydrochloride Tablets

Approval Number: 国药准字H20253016
Registration: Jan 2, 2025

Nicorandil Tablets

Approval Number: 国药准字H20253041
Registration: Jan 2, 2025

Glucosamine Sulfate Capsules

Approval Number: 国药准字H20253021
Registration: Jan 2, 2025

Vonoprazan Fumarate Tablets

Approval Number: 国药准字H20253008
Registration: Jan 2, 2025

Lidocaine and Prilocaine Cream

Approval Number: 国药准字H20253044
Registration: Jan 2, 2025

Dapoxetine Hydrochloride Tablets

Approval Number: 国药准字H20253015
Registration: Jan 2, 2025

Eldecalcitol Soft Capsules

Approval Number: 国药准字H20253039
Registration: Jan 2, 2025

Linezolid for Oral Suspension

Approval Number: 国药准字H20253003
Registration: Jan 2, 2025

Azelastine Hydrochloride Eye Drops

Approval Number: 国药准字H20253054
Registration: Jan 2, 2025

Eldecalcitol Soft Capsules

Approval Number: 国药准字H20253040
Registration: Jan 2, 2025

Oxcarbazepine Oral Suspension

Approval Number: 国药准字H20253025
Registration: Jan 2, 2025

Desloratadine Oral Solution

Approval Number: 国药准字H20253004
Registration: Jan 2, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.